Search clinical trials for: Premetrexed (Alimta)
Total 1188 results
-
Saint John's Cancer InstituteEli Lilly and Company; Chordoma FoundationCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedHistological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy.Hungary, Germany, Austria, Spain, Sweden
-
Duke UniversityEli Lilly and CompanyTerminatedNon Small Cell Lung CancerUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Eli Lilly and CompanyGenentech, Inc.Completed
-
Christiana Care Health ServicesEli Lilly and CompanyCompletedNon Small Cell Lung Cancer
-
Eli Lilly and CompanyTerminatedLung NeoplasmsBrazil, United States, India
-
PfizerCompletedCarcinoma, Non-Small Cell LungUnited States, Ukraine, Poland, Russian Federation, Taiwan, Italy, Spain, United Kingdom, Romania, Switzerland, Japan
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
The Netherlands Cancer InstitutePfizerCompletedMalignant Pleural MesotheliomaNetherlands
-
Eli Lilly and CompanyCompletedHead and Neck NeoplasmsUnited States
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedMalignant Pleural Mesothelioma | Pleural MesotheliomaUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Chang Gung Memorial HospitalTaiwan Chest Disease AssociationCompletedAdvanced Non-Squamous Non-Small Cell Lung CancerTaiwan
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck CancerUnited States
-
Accelerated Community Oncology Research NetworkEli Lilly and Company; Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Lantern Pharma Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Adenocarcinoma of LungUnited States
-
Eli Lilly and CompanyCompleted
-
Hoffmann-La RocheCompletedNon-small Cell Lung CancerBelgium, Italy, Portugal, Spain, Germany, Turkey, France, Hong Kong, Korea, Republic of, Poland, Russian Federation, Hungary, Norway, Bulgaria, Slovakia
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompletedNon Small Cell Lung CancerGreece
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid TumorUnited States
-
Effector TherapeuticsMedpace, Inc.; ICON plcActive, not recruitingNon-small Cell Lung CancerUnited States, Australia, Georgia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMetastatic Urothelial CarcinomaUnited States
-
PfizerCompleted
-
M.D. Anderson Cancer CenterRecruitingMetastatic Cancer | Urothelial CarcinomaUnited States
-
Bristol-Myers SquibbTerminatedSafety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung CancerLung Cancer - Non Small CellUnited States, Belgium, France, Germany, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerUnited Kingdom, Germany, Poland, Belgium, Spain, Italy, Greece, Australia, Netherlands, Romania, France, India, Finland, Turkey, Portugal
-
Chonnam National University HospitalSanofiTerminatedCarcinoma, Non Small Cell LungKorea, Republic of
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaboratorsCompletedNon Small Cell Lung CancerBelgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
-
Hangzhou ACEA Pharmaceutical Research Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesWithdrawn
-
The Netherlands Cancer InstituteWithdrawnNon-Small Cell Lung Cancer
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Julia K. Rotow, MDInivataActive, not recruitingMetastatic Non-Small Cell Lung Cancer | NSCLC Stage IVUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer
-
National Cancer Institute (NCI)WithdrawnAMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma
-
Eli Lilly and CompanyCompletedLung NeoplasmsUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Eli Lilly and CompanyCompleted
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Aduro Biotech, Inc.CompletedMalignant Pleural MesotheliomaUnited States
-
SCRI Development Innovations, LLCPfizerWithdrawnLung Cancer | Non-small Cell Lung CancerUnited States
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland